Other Species / Isoforms
  Claudin-5 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
G86
AARALTVGAVLLALV
0 1
Claudin-5 (human) AARALTVsAVLLAFV S86-p
Claudin-5 (mouse) AARALTVGAVLLALV G86
Claudin-5 (rat) AARALTVGAVLLALV G86
Y148
NIVVREFYDPTVPVS
1 1
Claudin-5 (human) NIVVREFyDPSVPVs Y148-p
Claudin-5 (mouse) NIVVREFYDPTVPVS Y148
Claudin-5 (rat) NIVVREFYDPTVPVS Y148
S155
YDPTVPVSQKYELGA
0 1
Claudin-5 (human) yDPSVPVsQKYELGA S155-p
Claudin-5 (mouse) YDPTVPVSQKYELGA S155
Claudin-5 (rat) YDPTVPVSQKYELGA S155
T207-p
YSAPRRPtANGDyDk
Upstream
Downstream
3 14
Effects on Modified Protein
  • activity, induced
Effects on Biological Processes:
  • cytoskeletal reorganization
Kinase, in vitro:
  • GRK1 (human)
Putative in vivo kinases:
  • GRK1 (human)
Treatment
  • cAMP_analog
  • LPA
  • Y27632
Claudin-5 (human) YSAPRRPtAtGDyDK T207-p
Claudin-5 (mouse) YSAPRRPtANGDyDk T207-p
Claudin-5 (rat) YSAPRRTTANGDYDK T207
N209
APRRPtANGDyDkkN
0 1
Claudin-5 (human) APRRPtAtGDyDKKN T209-p
Claudin-5 (mouse) APRRPtANGDyDkkN N209
Claudin-5 (rat) APRRTTANGDYDKKN N209
Y212-p
RPtANGDyDkkNyV_
0 54
Claudin-5 (human) RPtAtGDyDKKNyV_ Y212-p
Claudin-5 (mouse) RPtANGDyDkkNyV_ Y212-p
Claudin-5 (rat) RTTANGDYDKKNyV_ Y212
K214-ub
tANGDyDkkNyV___
0 2
Claudin-5 (human) tAtGDyDKKNyV___ K214
Claudin-5 (mouse) tANGDyDkkNyV___ K214-ub
Claudin-5 (rat) TANGDYDKKNyV___ K214
K215-ub
ANGDyDkkNyV____
0 1
Claudin-5 (human) AtGDyDKKNyV____ K215
Claudin-5 (mouse) ANGDyDkkNyV____ K215-ub
Claudin-5 (rat) ANGDYDKKNyV____ K215
Y217-p
GDyDkkNyV______
1 72
Claudin-5 (human) GDyDKKNyV______ Y217-p
Claudin-5 (mouse) GDyDkkNyV______ Y217-p
Claudin-5 (rat) GDYDKKNyV______ Y217-p